Type to search

Bioscience and pharmaceutical Economic Development Insider Only New Castle County News Public Companies

Prelude Therapeutics to raise $100M in share sale

Avatar photo

WILMINGTON – Prelude Therapeutics, the clinical-stage precision oncology company, announced Thursday that it’s selling millions of new shares in the publicly traded company to raise $100 million to support its drug pipeline. The sale marks the first major capital infusion in two years for Prelude, which is currently based at the DuPont Experimental Station but

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2023 Delaware Business Times